scholarly article | Q13442814 |
P356 | DOI | 10.1097/01.CCM.0000114821.25573.E7 |
P698 | PubMed publication ID | 15090969 |
P50 | author | Laura Dugo | Q44265120 |
Christoph Thiemermann | Q82195682 | ||
Marika Collin | Q82206141 | ||
P2093 | author name string | Nimesh S A Patel | |
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endotoxins | Q319997 |
P304 | page(s) | 826-831 | |
P577 | publication date | 2004-03-01 | |
P1433 | published in | Critical Care Medicine | Q5186605 |
P1476 | title | Role of peroxisome proliferator-activated receptor-gamma in the protection afforded by 15-deoxydelta12,14 prostaglandin J2 against the multiple organ failure caused by endotoxin | |
P478 | volume | 32 |
Q42474531 | A PPAR-gamma ligand, 15-deoxy-Delta12,14-prostaglandin J(2), inhibited gastric mucosal injury induced by ischemia-reperfusion in rats |
Q79775369 | A role of PPAR-gamma in androstenediol-mediated salutary effects on cardiac function following trauma-hemorrhage |
Q37211800 | Agonism of Peroxisome Proliferator Receptor-Gamma may have Therapeutic Potential for Neuroinflammation and Parkinson's Disease |
Q54581967 | Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitis. |
Q46660450 | Augmentation of endogenous cannabinoid tone modulates lipopolysaccharide-induced alterations in circulating cytokine levels in rats |
Q35638780 | Decreased hepatic peroxisome proliferator-activated receptor-γ contributes to increased sensitivity to endotoxin in obstructive jaundice |
Q46988945 | Effects of 15-deoxy-Delta12,14-prostaglandin-J2 during hyperdynamic porcine endotoxemia. |
Q34015516 | Inflammatory effects of phthalates in neonatal neutrophils |
Q37084532 | Mechanism of the Anti-inflammatory Effect of Curcumin: PPAR-gamma Activation |
Q35673358 | Novel Therapeutic Agents in Pediatric Sepsis: Peroxisome Proliferator Receptor γ (PPAR γ) Agonists |
Q36733873 | Nuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptors |
Q41585973 | Optimal study design for pioglitazone in septic pediatric patients |
Q37620186 | PPAR-γ/IL-10 axis inhibits MyD88 expression and ameliorates murine polymicrobial sepsis |
Q26771753 | PPARs: Protectors or Opponents of Myocardial Function? |
Q36605155 | PPARγ activation following apoptotic cell instillation promotes resolution of lung inflammation and fibrosis via regulation of efferocytosis and proresolving cytokines |
Q46889696 | Peroxisome proliferator activated receptor gamma is not necessary for the development of LPS-induced tolerance in macrophages |
Q34274262 | Phosphorylation of Extracellular Signal-Regulated Kinase (ERK)-1/2 Is Associated with the Downregulation of Peroxisome Proliferator-Activated Receptor (PPAR)-γ during Polymicrobial Sepsis |
Q44492991 | Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis |
Q84604261 | Role of PPARγ in the salutary effects of 17β‐estradiol on kupffer cell cytokine production following trauma‐hemorrhage |
Q36519265 | Sesamol ameliorates hypotension by modulating cytokines and PPAR-gamma in systemic inflammatory response |
Q38565307 | Statins, fibrates, thiazolidinediones and resveratrol as adjunctive therapies in sepsis: could mitochondria be a common target? |
Q57840024 | Telmisartan, a dual ARB/partial PPAR-γ agonist, protects myocardium from ischaemic reperfusion injury in experimental diabetes |
Q46469543 | The cyclopentenone prostaglandin 15-deoxydelta(12,14)-prostaglandin J2 attenuates the development of zymosan-induced shock |
Search more.